シングルユースバイオリアクター市場：製品別（システム、2D、3Dメディアバッグ、フィルトレーションアセンブリ）、分子別（mAbs、ワクチン）、細胞タイプ別（Mammalian、Bacteria）、用途別（R&D、プロセス開発）、エンドユーザー別（バイオファーマ、CRO、CMO） - 2026年までの世界予測

Single-use Bioreactors Market by Product (System, 2D, 3D Media Bag, Filtration Assemblies), Molecule (mAbs, Vaccine), Cell type (Mammalian, Bacteria), Application (R&D, Process Development), End User (Biopharma, CROs & CMOs) - Global Forecast to 2026

シングルユースバイオリアクターの世界市場は、予測期間中に21.1%のCAGRで推移し、2021年の34億米ドルから2026年には88億米ドルに達すると予測されています。小規模企業や新興企業でのSUBの採用増加、自動化の複... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2021年8月19日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	350	532	英語

※ 調査会社の事情により、予告なしに価格が変更になる場合がございます。
最新の価格はデータリソースまでご確認ください。
日本語のページは自動翻訳を利用し作成しています。

サマリー

シングルユースバイオリアクターの世界市場は、予測期間中に21.1%のCAGRで推移し、2021年の34億米ドルから2026年には88億米ドルに達すると予測されています。小規模企業や新興企業でのSUBの採用増加、自動化の複雑さの軽減、海洋生物の培養の容易さ、エネルギーと水の消費量の削減、バイオロジクス市場の拡大、SUBの技術的進歩、バイオ医薬品の研究開発の増加などが、この市場の成長を促進する要因となっています。
"タイプ別では、撹拌槽型SUBがシングルユースバイオリアクター市場で最大のシェアを占めています。"
シングルユースバイオリアクター市場は、大きく分けて波動式SUB、撹拌式タンクSUB、バブルカラムSUB、その他のバイオリアクターの4つのタイプに分類されます。2020年のシングルユースバイオリアクター市場では、撹拌槽型SUBsセグメントが主流となっています。このセグメントの大きなシェアは、好気性微生物の培養において、酸素の移動が大きく、熱除去や物質移動、高い撹拌速度などのエンジニアリング上の課題が軽減されるため、撹拌槽SUBが好まれていることなどに起因しています。
"アジア太平洋シングルユースバイオリアクター市場で最も急速に成長している地域"
アジア太平洋市場は、主にバイオ医薬品産業の成長、ライフサイエンス研究の増加、製薬会社やバイオテクノロジー企業による投資の増加、APACのいくつかの国におけるCROやCMOの増加が成長に寄与していることから、予測期間中に最も高いCAGRで成長すると予測されています。
"北米：シングルユースバイオリアクター市場で最大のシェア"
シングルユースバイオリアクター市場では、北米が最大のシェアを占めています。この地域では、確立されたバイオ医薬品産業が存在することや、シングルユースバイオリアクター市場に参入している大手企業が存在することなどが、市場成長の主な要因となっています。
プライマリーの内訳

本調査では、部品メーカーからTier1企業、OEMまで、さまざまな業界の専門家による知見が得られています。プライマリーの内訳は以下の通りです。
回答者別-供給側-70%、需要側-30
回答者別：サプライサイド70％、デマンドサイド30％、役職別：エグゼクティブ25％、CXO、ディレクター20％、マネージャー55
地域別-北米：50%、欧州：20%、APAC：20%、RoW：10
シングルユースバイオリアクター市場は、Sartorius Stedim Biotech社（フランス）、Thermo Fisher Scientific社（米国）、Danaher Corporation社（米国）、Merck KGaA社（ドイツ）、Getinge AB社（スウェーデン）、Eppendorf AG社（ドイツ）、CESCO Bioengineering社（米国）、Cellexus社（米国）、PBS Biotech Inc.(米国）、Distek Inc.(アメリカ）、ABEC（アメリカ）、エイブル株式会社・株式会社バイオット（日本）、G&G Technologies Inc.(米国)、Solida Biotech GmBH (ドイツ)、佐竹化学機器製作所 (日本)、Stobbe Pharma, Inc.(日本), Stobbe Pharma GmBH (ドイツ), Celltainer Biotech BV (オランダ), Meissner Filtration Products Inc.(米国)、bbi-biotech GmBH(ドイツ)、ENDEL ENGIE(フランス)、OmniBRx biotechnologies(インド)、New Horizon Biotechnology Inc.(米国）、GPC Bio（米国）、Cell culture company（米国）、Aptus bioreactors（米国）などがあります。
リサーチカバレッジ

当レポートでは、シングルユースバイオリアクター市場を、地域（北米、欧州、アジア太平洋、中南米、中東・アフリカ）、製品（シングルユースバイオリアクターシステム（10Lまで、11-100L、101-500L、01-1500L、1500L以上）、シングルユースメディアバッグ（2Dバッグ、3Dバッグ、その他のバッグ）、シングルユースフィルトレーションアセンブリ、その他の製品）、タイプ（撹拌槽型SUB、波動型SUB,その他のSUB）、細胞の種類（哺乳類細胞、バクテリア細胞、酵母細胞、その他の細胞）、分子の種類（モノクローナル抗体、ワクチン、遺伝子改変細胞、幹細胞、その他の分子）、用途（研究開発、プロセス開発、バイオプロダクション）、エンドユーザー（製薬・バイオ製薬企業、CRO・CMO、学術・研究機関）などがあります。
また、シングルユースバイオリアクター市場の市場促進要因、課題、機会についても包括的に考察しています。
このレポートを購入する主なメリット

本レポートは、この市場のリーダー/新規参入者が、市場全体およびサブセグメントの収益数値の最も近い近似値に関する情報を得るのに役立ちます。本レポートは、ステークホルダーが競争状況を理解し、ビジネスをより良く位置づけ、適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、ステークホルダーがシングルユースバイオリアクター市場の脈動を理解し、主要な市場ドライバー、課題、機会に関する情報を提供します。

ページTOPに戻る

Table of Contents

Summary

The global single-use bioreactors market is projected to reach USD 8.8 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 21.1% during the forecast period. Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption, the growing biologics market, technological advancements in SUBs, and increasing Biopharmaceutical R&D are factors driving the growth of this market.
“By type, the stirred-tank SUBs segment accounted for the largest share of the single-use bioreactors market”
The single-use bioreactors market is categorized into major four types, wave-induced SUBs, stirred-tank SUBs, bubble-column SUBs, and other bioreactors. The stirred-tank SUBs segment dominated the single-use bioreactors market in 2020. The large share of this segment can be attributed to factors such as the high preference for stirred-tank SUBs in the cultivation of aerobic microbial cultures due to its ability to provide greater oxygen transfer and reduced engineering challenges such as heat removal, mass transfer, and higher agitation rates.
“Asia Pacific: The fastest-growing region in the single-use bioreactors market.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the growing biopharmaceutical industry, increasing life science research, rising investments by pharmaceutical and biotechnology companies, and the growing number of CROs and CMOs in several APAC countries contribute to its growth.
“North America: the largest share of the single-use bioreactors market”
North America accounted for the largest share of the single-use bioreactors market. Factors such as the to the presence of established biopharmaceutical industry and the presence of major players operating in the single-use bioreactors market in the region are the major factors driving the market growth.
Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
By Respondent– Supply Side- 70%, Demand Side- 30%
By Designation— Executives- 25%, CXOs, Directors- 20%, Managers - 55%
By Region— North America - 50%, Europe - 20%, APAC – 20%, RoW- 10%
The single-use bioreactors market is dominated by a few globally established players such as Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Merck KGaA (Germany), Getinge AB (Sweden), Eppendorf AG (Germany), CESCO Bioengineering (US), Cellexus (US), PBS Biotech Inc. (US), Distek Inc. (US), ABEC (US), Able Corporation & Biott Corporation (Japan), G&G Technologies Inc. (US), Solida Biotech GmBH (Germany), Satake Chemical Equipment Mfg., Ltd. (Japan), Stobbe Pharma GmBH (Germany), Celltainer Biotech BV (Netherlands), Meissner Filtration Products Inc. (US), bbi-biotech GmBH (Germany), ENDEL ENGIE (France), OmniBRx biotechnologies (India), New Horizon Biotechnology Inc. (US), GPC Bio (US), Cell culture company (US), and Aptus bioreactors (US).
Research Coverage:

The report segments the single-use bioreactors market based on region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), products (Single-use bioreactor systems (up to 10L, 11–100L, 101–500L, 01–1500L, above 1500L), single-use media bags (2D bags, 3D bags, other bags), single-use filtration assemblies, and other products), type (Stirred-tank SUBs, wave-induced SUBs, bubble-column SUBs, and other SUBs), Type of Cell (Mammalian cells, bacterial cells, yeast cells, and other cells), Molecule Type (Monoclonal antibodies, vaccines, gene-modified cells, stem cells, and other molecules), application (Research & development, process development, and bioproduction), end users (Pharmaceutical & biopharmaceutical companies, CROs and CMOs, and academic & research Institutes).
The report also provides a comprehensive review of market drivers, challenges, and opportunities in the single-use bioreactors market
Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the single-use bioreactors market and provides them information on key market drivers, challenges, and opportunities.

ページTOPに戻る

1 INTRODUCTION 54
1.1 OBJECTIVES OF THE STUDY 54
1.2 MARKET DEFINITION 55
1.2.1 INCLUSIONS & EXCLUSIONS 55
1.3 MARKET SCOPE 56
1.3.1 MARKETS COVERED 56
1.3.2 YEARS CONSIDERED FOR THE STUDY 57
1.4 CURRENCY 57
1.5 LIMITATIONS 57
1.6 STAKEHOLDERS 58
1.7 SUMMARY OF CHANGES 58
2 RESEARCH METHODOLOGY 60
2.1 RESEARCH DATA 60
FIGURE 1 RESEARCH DESIGN 60
2.1.1 SECONDARY DATA 61
2.1.2 PRIMARY DATA 62
FIGURE 2 BREAKDOWN OF PRIMARIES: SINGLE-USE BIOREACTORS MARKET 62
2.2 MARKET ESTIMATION METHODOLOGY 63
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1
(REVENUE-BASED ESTIMATION), 2020 63
FIGURE 4 SINGLE-USE BIOREACTORS MARKET SIZE
ESTIMATION (SUPPLY-SIDE ANALYSIS) 2020 64
FIGURE 5 SINGLE-USE BIOREACTORS MARKET SIZE ESTIMATION (DEMAND-SIDE ANALYSIS) FOR 2020 65
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 66
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 66
2.3 MARKET GROWTH RATE PROJECTIONS 66
FIGURE 7 SINGLE-USE BIOREACTORS MARKET (SUPPLY-SIDE): CAGR PROJECTIONS 67
FIGURE 8 SINGLE-USE BIOREACTORS MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS 68
2.3.1 INSIGHTS FROM PRIMARY EXPERTS 69
FIGURE 9 MARKET FORECAST VALIDATION FROM PRIMARY SOURCES 69
2.3.2 DATA TRIANGULATION 70
FIGURE 10 DATA TRIANGULATION METHODOLOGY 70
2.4 RESEARCH ASSUMPTIONS 71
2.4.1 COVID-19 SPECIFIC ASSUMPTIONS 71
2.5 RISK ANALYSIS 72

3 EXECUTIVE SUMMARY 73
FIGURE 11 SINGLE-USE BIOREACTORS MARKET SHARE, BY PRODUCT, 2020 73
FIGURE 12 SINGLE-USE BIOREACTORS MARKET SHARE, BY TYPE, 2020 74
FIGURE 13 SINGLE-USE BIOREACTORS MARKET SHARE, BY TYPE OF CELL, 2020 74
FIGURE 14 SINGLE-USE BIOREACTORS MARKET SHARE, BY TYPE OF MOLECULE, 2020 75
FIGURE 15 SINGLE-USE BIOREACTORS MARKET SHARE, BY APPLICATION, 2020 76
FIGURE 16 SINGLE-USE BIOREACTORS MARKET, BY END USER, 2020 (USD MILLION) 76
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE SINGLE-USE
BIOREACTORS MARKET, 2020 77
4 PREMIUM INSIGHTS 78
4.1 SINGLE-USE BIOREACTORS MARKET OVERVIEW 78
FIGURE 18 INCREASING ADOPTION OF SUBS AMONG SMALL COMPANIES AND STARTUPS TO SUPPORT THE MARKET GROWTH 78
4.2 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SHARE, BY PRODUCT & COUNTRY (2020) 79
FIGURE 19 THE SINGLE-USE BIOREACTOR SYSTEMS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN SINGLE-USE BIOREACTORS MARKET IN 2020 79
4.3 SINGLE-USE BIOREACTORS MARKET SHARE, BY END USER, 2021 VS. 2026 80
FIGURE 20 THE PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 80
4.4 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 81
FIGURE 21 THE BIOPRODUCTION SEGMENT WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 81
4.5 SINGLE-USE BIOREACTORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 82
FIGURE 22 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH IN THE SINGLE-USE BIOREACTORS MARKET DURING THE FORECAST PERIOD (2021─2026) 82
5 MARKET OVERVIEW 83
5.1 INTRODUCTION 83
5.2 MARKET DYNAMICS 83
FIGURE 23 GLOBAL SINGLE-USE BIOREACTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 83
TABLE 1 SINGLE-USE BIOREACTORS MARKET: IMPACT ANALYSIS 84
5.2.1 DRIVERS 84
5.2.1.1 Increasing adoption of SUBs among small companies and startups 84
FIGURE 24 ADOPTION OF SINGLE-USE PRODUCTS IN BIOPHARMACEUTICAL MANUFACTURING (2019) 85
5.2.1.2 Reduced automation complexity 85
5.2.1.3 Ease in the cultivation of marine organisms 86
5.2.1.4 Reduced energy and water consumption 86
5.2.1.5 Growing biologics market 86

FIGURE 25 GLOBAL BIOLOGICS MARKET, 2014─2023 (USD BILLION) 87
5.2.1.6 Technological advancements in SUBs 87
5.2.1.7 Increasing biopharmaceutical R&D 87
FIGURE 26 GLOBAL R&D INVESTMENTS BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2010-2025 (USD BILLION) 88
5.2.2 RESTRAINTS 88
5.2.2.1 Regulatory concerns related to SUBs 88
5.2.2.2 Issues related to leachables and extractables 89
5.2.3 OPPORTUNITIES 89
5.2.3.1 Patent expiry 89
TABLE 2 US: BIOLOGICS GOING OFF-PATENT DURING 2018–2025 89
5.2.3.2 Emerging markets 90
5.2.4 CHALLENGES 90
5.2.4.1 Need for improved single-use sensors 90
5.2.4.2 Standardization of single-use designs 90
5.3 KEY INDUSTRY TRENDS 91
5.3.1 INCREASING FOCUS OF SINGLE-USE BIOPROCESSING CAPACITIES AND TECHNOLOGICAL COMPETITIVENESS 91
TABLE 3 SINGLE-USE BIOREACTOR CAPACITY EXPANSIONS BY MAJOR PLAYERS 91
5.3.2 INCREASING ADOPTION OF SINGLE-USE SYSTEMS BY CONTRACT MANUFACTURING ORGANIZATIONS 92
5.3.3 ADVENT OF AUTOMATION IN SINGLE-USE BIOREACTORS 92
5.4 IMPACT OF THE COVID-19 OUTBREAK ON THE SINGLE-USE BIOREACTORS MARKET 93
FIGURE 27 SINGLE-USE BIOREACTORS MARKET SCENARIO WITH AND WITHOUT THE COVID-19 IMPACT (2019-2021) 94
5.5 TRENDS/DISRUPTIONS IMPACTING CONSUMER BUSINESS 95
FIGURE 28 REVENUE SHIFT FOR SUB PROVIDERS 95
5.6 PRICING ANALYSIS 95
TABLE 4 AVERAGE SELLING PRICE OF LAB SCALE SINGLE-USE BIOREACTORS
BY REGION (2019) 95
TABLE 5 APAC: AVERAGE COST OF SINGLE-USE BAGS/CYCLE (2020) 96
5.7 VALUE CHAIN ANALYSIS 96
FIGURE 29 VALUE CHAIN ANALYSIS ECOSYSTEM OF SINGLE-USE BIOREACTORS:
R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE 96
5.8 TECHNOLOGICAL ANALYSIS 98
5.8.1 WAVE-INDUCED MOTION TECHNOLOGY 99
5.8.2 BUBBLE-COLUMN TECHNOLOGY 99
5.8.3 STIRRED-TANK TECHNOLOGY 99
5.8.4 VERTICALLY PERFORATED DISCS 99
5.9 PORTER’S FIVE FORCES ANALYSIS 99
TABLE 6 SINGLE-USE BIOREACTORS MARKET: PORTER’S FIVE FORCES ANALYSIS 99
5.9.1 THREAT FROM NEW ENTRANTS 100
5.9.2 THREAT FROM SUBSTITUTES 100
5.9.3 BARGAINING POWER OF SUPPLIERS 100
5.9.4 BARGAINING POWER OF BUYERS 100
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 101
5.10 PATENT ANALYSIS 101
FIGURE 30 NUMBER OF SINGLE-USE BIOREACTORS MARKET PATENTS GRANTED (2010–2020) 101
5.10.1 LIST OF RECENT PATENTS 102
5.11 REGULATORY LANDSCAPE 102
5.11.1 NORTH AMERICA 102
5.11.1.1 US 102
TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION 103
TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 103
5.11.1.2 Canada 103
5.11.1.3 Europe 103
6 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT 105
6.1 INTRODUCTION 106
TABLE 9 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 106
TABLE 10 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 106
6.2 SINGLE-USE BIOREACTOR SYSTEMS 107
6.2.1 THE SINGLE-USE BIOREACTOR SYSTEMS SEGMENT
DOMINATED THE MARKET IN 2020 107
TABLE 11 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION,
2017–2020 (USD MILLION) 107
TABLE 12 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION,
2021–2026 (USD MILLION) 108
TABLE 13 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2017–2020 (USD MILLION) 108
TABLE 14 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2021–2026 (USD MILLION) 108
TABLE 15 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 109
TABLE 16 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 109
TABLE 17 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 109
TABLE 18 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 110
TABLE 19 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE,
2017–2020 (USD MILLION) 110
TABLE 20 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE,
2021–2026 (USD MILLION) 111
TABLE 21 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE,
2017–2020 (UNITS) 111
TABLE 22 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE,
2021–2026 (UNITS) 111
6.2.2 UP TO 10L 112
TABLE 23 UP TO 10L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION,
2017–2020 (USD MILLION) 112
TABLE 24 UP TO 10L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION,
2021–2026 (USD MILLION) 112
6.2.3 11–100L 112
TABLE 25 11–100L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION,
2017–2020 (USD MILLION) 113
TABLE 26 11–100L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION,
2021–2026 (USD MILLION) 113
6.2.4 101–500L 113
TABLE 27 101–500L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION,
2017–2020 (USD MILLION) 114
TABLE 28 101–500L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION,
2021–2026 (USD MILLION) 114
6.2.5 501–1500L 115
TABLE 29 501–1500L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2017–2020 (USD MILLION) 115
TABLE 30 501–1500L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2026 (USD MILLION) 115
6.2.6 ABOVE 1500L 115
TABLE 31 ABOVE 1,500L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2017–2020 (USD MILLION) 116
TABLE 32 ABOVE 1,500L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2026 (USD MILLION) 116
6.3 SINGLE-USE MEDIA BAGS 117
6.3.1 EXPANDED APPLICATIONS OF SINGLE-USE BAGS ACROSS BIOPROCESS OPERATIONS DRIVE MARKET GROWTH FOR THIS SEGMENT 117
TABLE 33 SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2017–2020 (USD MILLION) 117
TABLE 34 SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2021–2026 (USD MILLION) 118
TABLE 35 NORTH AMERICA: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 118
TABLE 36 NORTH AMERICA: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 118
TABLE 37 EUROPE: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 119
TABLE 38 EUROPE: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 119
TABLE 39 ASIA PACIFIC: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 119
TABLE 40 ASIA PACIFIC: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 120
TABLE 41 SINGLE-USE MEDIA BAGS MARKET, BY TYPE, 2017–2020 (USD MILLION) 120
TABLE 42 SINGLE-USE MEDIA BAGS MARKET, BY TYPE, 2021–2026 (USD MILLION) 120
6.3.2 2D BAGS 121
TABLE 43 2D BAGS MARKET, BY REGION, 2017–2020 (USD MILLION) 121
TABLE 44 2D BAGS MARKET, BY REGION, 2021–2026 (USD MILLION) 121
6.3.3 3D BAGS 122
TABLE 45 3D BAGS MARKET, BY REGION, 2017–2020 (USD MILLION) 122
TABLE 46 3D BAGS MARKET, BY REGION, 2021–2026 (USD MILLION) 122
6.3.4 OTHER BAGS 123
TABLE 47 OTHER BAGS MARKET, BY REGION, 2017–2020 (USD MILLION) 123
TABLE 48 OTHER BAGS MARKET, BY REGION, 2021–2026 (USD MILLION) 123
6.4 SINGLE-USE FILTRATION ASSEMBLIES 124
6.4.1 REDUCED RISK OF CONTAMINATION HAS PROPELLED THE DEMAND FOR SINGLE-USE FILTRATION ASSEMBLIES 124
TABLE 49 SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY REGION,
2017–2020 (USD MILLION) 124
TABLE 50 SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY REGION,
2021–2026 (USD MILLION) 124
TABLE 51 NORTH AMERICA: SINGLE-USE FILTRATION ASSEMBLIES MARKET,
BY COUNTRY, 2017–2020 (USD MILLION) 125
TABLE 52 NORTH AMERICA: SINGLE-USE FILTRATION ASSEMBLIES MARKET,
BY COUNTRY, 2021–2026 (USD MILLION) 125
TABLE 53 EUROPE: SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 125
TABLE 54 EUROPE: SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 126
TABLE 55 ASIA PACIFIC: SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 126
TABLE 56 ASIA PACIFIC: SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 126
6.5 OTHER PRODUCTS 127
TABLE 57 OTHER PRODUCTS MARKET, BY REGION, 2017–2020 (USD MILLION) 127
TABLE 58 OTHER PRODUCTS MARKET, BY REGION, 2021–2026 (USD MILLION) 128
TABLE 59 NORTH AMERICA: OTHER PRODUCTS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 128
TABLE 60 NORTH AMERICA: OTHER PRODUCTS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 128
TABLE 61 EUROPE: OTHER PRODUCTS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 129
TABLE 62 EUROPE: OTHER PRODUCTS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 129
TABLE 63 ASIA PACIFIC: OTHER PRODUCTS MARKET, BY COUNTRY/REGION,
2017–2020 (USD MILLION) 129
TABLE 64 ASIA PACIFIC: OTHER PRODUCTS MARKET, BY COUNTRY/REGION,
2021–2026 (USD MILLION) 130

7 SINGLE-USE BIOREACTORS MARKET, BY TYPE 131
7.1 INTRODUCTION 132
TABLE 65 SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2017–2020 (USD MILLION) 132
TABLE 66 SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2026 (USD MILLION) 132
7.2 STIRRED-TANK SINGLE-USE BIOREACTORS 132
7.2.1 STIRRED-TANK SUBS ARE MOSTLY PREFERRED IN THE CULTIVATION OF AEROBIC MICROBIAL CULTURES 132
TABLE 67 STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY REGION,
2017–2020 (USD MILLION) 133
TABLE 68 STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY REGION,
2021–2026 (USD MILLION) 133
TABLE 69 NORTH AMERICA: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2017–2020 (USD MILLION) 134
TABLE 70 NORTH AMERICA: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2021–2026 (USD MILLION) 134
TABLE 71 EUROPE: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 134
TABLE 72 EUROPE: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 135
TABLE 73 APAC: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 135
TABLE 74 APAC: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 135
7.3 WAVE-INDUCED SINGLE-USE BIOREACTORS 136
7.3.1 LOW INVESTMENT COSTS AND SUCCESSFUL APPLICATIONS HAVE INCREASED THE ADOPTION OF WAVE-INDUCED SUBS IN
THE BIOREACTORS MARKET 136
TABLE 75 WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY REGION,
2017–2020 (USD MILLION) 136
TABLE 76 WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY REGION,
2021–2026 (USD MILLION) 137
TABLE 77 NORTH AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2017–2020 (USD MILLION) 137
TABLE 78 NORTH AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2021–2026 (USD MILLION) 137
TABLE 79 EUROPE: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 138
TABLE 80 EUROPE: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 138
TABLE 81 APAC: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 138
TABLE 82 APAC: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 139
7.4 BUBBLE-COLUMN SINGLE-USE BIOREACTORS 139
7.4.1 GREATER MASS AND HEAT TRANSFER EFFICIENCIES DRIVE THE GROWTH OF THIS SEGMENT 139
TABLE 83 BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY REGION,
2017–2020 (USD MILLION) 139
TABLE 84 BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY REGION,
2021–2026 (USD MILLION) 140
TABLE 85 NORTH AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2017–2020 (USD MILLION) 140
TABLE 86 NORTH AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2021–2026 (USD MILLION) 140
TABLE 87 EUROPE: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2017–2020 (USD MILLION) 141
TABLE 88 EUROPE: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2021–2026 (USD MILLION) 141
TABLE 89 APAC: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 141
TABLE 90 APAC: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 142
7.5 OTHER SINGLE-USE BIOREACTORS 142
TABLE 91 OTHER SINGLE-USE BIOREACTORS MARKET, BY REGION,
2017–2020 (USD MILLION) 142
TABLE 92 OTHER SINGLE-USE BIOREACTORS MARKET, BY REGION,
2021–2026 (USD MILLION) 143
TABLE 93 NORTH AMERICA: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 143
TABLE 94 NORTH AMERICA: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 143
TABLE 95 EUROPE: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 144
TABLE 96 EUROPE: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 144
TABLE 97 APAC: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 144
TABLE 98 APAC: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 145
8 SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL 146
8.1 INTRODUCTION 147
TABLE 99 SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,
2017–2020 (USD MILLION) 147
TABLE 100 SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,
2021–2026 (USD MILLION) 147
8.2 MAMMALIAN CELLS 148
8.2.1 MAMMALIAN CELLS ARE MOST WIDELY USED IN BIOMANUFACTURING OWING TO THEIR HIGHLY MECHANIZED METABOLIC MACHINERY 148
TABLE 101 SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY REGION, 2017–2020 (USD MILLION) 148
TABLE 102 SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY REGION, 2021–2026 (USD MILLION) 149
TABLE 103 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2017–2020 (USD MILLION) 149
TABLE 104 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2021–2026 (USD MILLION) 149
TABLE 105 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS,
BY COUNTRY, 2017–2020 (USD MILLION) 150
TABLE 106 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS,
BY COUNTRY, 2021–2026 (USD MILLION) 150
TABLE 107 APAC: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS,
BY COUNTRY, 2017–2020 (USD MILLION) 150
TABLE 108 APAC: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS,
BY COUNTRY, 2021–2026 (USD MILLION) 151
8.3 BACTERIAL CELLS 151
8.3.1 THE USE OF BACTERIAL CELLS IN COMMERCIAL VACCINES AND RECOMBINANT PROTEIN PRODUCTION DRIVES THE MARKET GROWTH 151
TABLE 109 SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY REGION, 2017–2020 (USD MILLION) 151
TABLE 110 SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY REGION, 2021–2026 (USD MILLION) 152
TABLE 111 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2017–2020 (USD MILLION) 152
TABLE 112 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2021–2026 (USD MILLION) 152
TABLE 113 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY COUNTRY, 2017–2020 (USD MILLION) 153
TABLE 114 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY COUNTRY, 2021–2026 (USD MILLION) 153
TABLE 115 APAC: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY COUNTRY, 2017–2020 (USD MILLION) 153
TABLE 116 APAC: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY COUNTRY, 2021–2026 (USD MILLION) 154
8.4 YEAST CELLS 154
8.4.1 FASTER GROWTH RATE AND MINIMAL REQUIREMENT OF GROWTH MEDIA CONDITIONS DRIVES THE ADOPTION OF YEAST CELLS IN RECOMBINANT PROTEIN PRODUCTION 154
TABLE 117 SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY REGION,
2017–2020 (USD MILLION) 155
TABLE 118 SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY REGION,
2021–2026 (USD MILLION) 155
TABLE 119 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY COUNTRY, 2017–2020 (USD MILLION) 155
TABLE 120 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY COUNTRY, 2021–2026 (USD MILLION) 156
TABLE 121 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY COUNTRY, 2017–2020 (USD MILLION) 156
TABLE 122 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY COUNTRY, 2021–2026 (USD MILLION) 156
TABLE 123 APAC: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2017–2020 (USD MILLION) 157
TABLE 124 APAC: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY COUNTRY/REGION, 2021–2026 (USD MILLION) 157
8.5 OTHER CELLS 157
TABLE 125 SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY REGION,
2017–2020 (USD MILLION) 158
TABLE 126 SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY REGION,
2021–2026 (USD MILLION) 158
TABLE 127 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY COUNTRY, 2017–2020 (USD MILLION) 158
TABLE 128 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY COUNTRY, 2021–2026 (USD MILLION) 159
TABLE 129 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY COUNTRY, 2017–2020 (USD MILLION) 159
TABLE 130 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY COUNTRY, 2021–2026 (USD MILLION) 159
TABLE 131 APAC: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2017–2020 (USD MILLION) 160
TABLE 132 APAC: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2021–2026 (USD MILLION) 160
9 SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE 161
9.1 INTRODUCTION 162
TABLE 133 SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,
2017–2020 (USD MILLION) 162
TABLE 134 SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,
2021–2026 (USD MILLION) 162
9.2 MONOCLONAL ANTIBODIES 162
9.2.1 GROWING THERAPEUTIC APPLICATIONS OF MABS TO DRIVE THE DEMAND FOR SUBS IN R&D MANUFACTURING APPLICATIONS 162
TABLE 135 SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES,
BY REGION, 2017–2020 (USD MILLION) 163
TABLE 136 SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES,
BY REGION, 2021–2026 (USD MILLION) 164
TABLE 137 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2017–2020 (USD MILLION) 164
TABLE 138 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021–2026 (USD MILLION) 164
TABLE 139 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2017–2020 (USD MILLION) 165
TABLE 140 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021–2026 (USD MILLION) 165
TABLE 141 APAC: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2017–2020 (USD MILLION) 165
TABLE 142 APAC: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021–2026 (USD MILLION) 166
9.3 VACCINES 166
9.3.1 IMPLEMENTATION OF SUBS FOR VACCINE PRODUCTION MAXIMIZES FACILITY OUTPUT AND INCREASES REVENUE 166
TABLE 143 SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY REGION,
2017–2020 (USD MILLION) 167
TABLE 144 SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY REGION,
2021–2026 (USD MILLION) 167
TABLE 145 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR VACCINES,
BY COUNTRY, 2017–2020 (USD MILLION) 167
TABLE 146 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR VACCINES,
BY COUNTRY, 2021–2026 (USD MILLION) 168
TABLE 147 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2017–2020 (USD MILLION) 168
TABLE 148 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2021–2026 (USD MILLION) 168
TABLE 149 APAC: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2017–2020 (USD MILLION) 169
TABLE 150 APAC: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2021–2026 (USD MILLION) 169
9.4 STEM CELLS 169
9.4.1 WIDE APPLICATIONS OF STEM CELL THERAPIES FOR DISEASE TREATMENT DRIVES THE MARKET GROWTH OF THIS SEGMENT 169
TABLE 151 SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY REGION,
2017–2020 (USD MILLION) 170
TABLE 152 SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY REGION,
2021–2026 (USD MILLION) 170
TABLE 153 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS,
BY COUNTRY, 2017–2020 (USD MILLION) 170
TABLE 154 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS,
BY COUNTRY, 2021–2026 (USD MILLION) 171
TABLE 155 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS,
BY COUNTRY, 2017–2020 (USD MILLION) 171
TABLE 156 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS
, BY COUNTRY, 2021–2026 (USD MILLION) 171
TABLE 157 APAC: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY COUNTRY, 2017–2020 (USD MILLION) 172
TABLE 158 APAC: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY COUNTRY, 2021–2026 (USD MILLION) 172
9.5 GENE–MODIFIED CELLS 172
9.5.1 THE GROWING MARKET OF GENE AND CELL THERAPIES FOR NEUROLOGICAL DISEASES AND CANCER TO DRIVE THE GROWTH OF THIS SEGMENT 172
TABLE 159 SINGLE-USE BIOREACTORS MARKET FOR GENE-MODIFIED CELLS,
BY REGION, 2017–2020 (USD MILLION) 173
TABLE 160 SINGLE-USE BIOREACTORS MARKET FOR GENE-MODIFIED CELLS,
BY REGION, 2021–2026 (USD MILLION) 173
TABLE 161 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR GENE-MODIFIED CELLS, BY COUNTRY, 2017–2020 (USD MILLION) 174
TABLE 162 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR GENE-MODIFIED CELLS, BY COUNTRY, 2021–2026 (USD MILLION) 174
TABLE 163 EUROPE: SINGLE-USE BIOREACTORS MARKET GENE –MODIFIED CELLS,
BY COUNTRY, 2017–2020 (USD MILLION) 174
TABLE 164 EUROPE: SINGLE-USE BIOREACTORS MARKET GENE –MODIFIED CELLS,
BY COUNTRY, 2021–2026 (USD MILLION) 175
TABLE 165 APAC: SINGLE-USE BIOREACTORS MARKET FOR GENE-MODIFIED CELLS,
BY COUNTRY, 2017–2020 (USD MILLION) 175
TABLE 166 APAC: SINGLE-USE BIOREACTORS MARKET FOR GENE-MODIFIED CELLS,
BY COUNTRY, 2021–2026 (USD MILLION) 175
9.6 OHER MOLECULES 176
TABLE 167 SINGLE-USE BIOREACTORS MARKET FOR OTHER MOLECULES, BY REGION, 2017–2020 (USD MILLION) 176
TABLE 168 SINGLE-USE BIOREACTORS MARKET FOR OTHER MOLECULES, BY REGION, 2021–2026 (USD MILLION) 176
TABLE 169 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2017–2020 (USD MILLION) 177
TABLE 170 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2021–2026 (USD MILLION) 177
TABLE 171 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR OTHER MOLECULES,
BY COUNTRY, 2017–2020 (USD MILLION) 177
TABLE 172 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR OTHER MOLECULES,
BY COUNTRY, 2021–2026 (USD MILLION) 178
TABLE 173 APAC: SINGLE-USE BIOREACTORS MARKET FOR OTHER MOLECULES,
BY COUNTRY, 2017–2020 (USD MILLION) 178
TABLE 174 APAC: SINGLE-USE BIOREACTORS MARKET FOR OTHER MOLECULES,
BY COUNTRY, 2021–2026 (USD MILLION) 178
10 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION 179
10.1 INTRODUCTION 180
TABLE 175 GLOBAL SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 180
TABLE 176 GLOBAL SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 180
10.2 BIOPRODUCTION 181
10.2.1 INCREASING COMPETITION FOR NEW INDICATIONS AND THE LAUNCH OF BIOSIMILARS DRIVES THE DEMAND FOR COST-EFFECTIVE SUBS 181
TABLE 177 SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY REGION, 2017–2020 (USD MILLION) 181
TABLE 178 SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY REGION, 2021–2026 (USD MILLION) 182
TABLE 179 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2017–2020 (USD MILLION) 182
TABLE 180 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2021–2026 (USD MILLION) 182
TABLE 181 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY COUNTRY, 2017–2020 (USD MILLION) 183
TABLE 182 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY COUNTRY, 2021–2026 (USD MILLION) 183
TABLE 183 APAC: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY COUNTRY, 2017–2020 (USD MILLION) 183
TABLE 184 APAC: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY COUNTRY, 2021–2026 (USD MILLION) 184
10.3 PROCESS DEVELOPMENT 184
10.3.1 REDUCED RISK OF CROSS-CONTAMINATION AND REDUCED OPERATIONAL COSTS MAKE SUBS THE MOST PREFERRED SOLUTION FOR PROCESS DEVELOPMENT 184
TABLE 185 SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT,
BY REGION, 2017–2020 (USD MILLION) 184
TABLE 186 SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT,
BY REGION, 2021–2026 (USD MILLION) 185
TABLE 187 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION) 185
TABLE 188 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION) 185
TABLE 189 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION) 186
TABLE 190 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION) 186
TABLE 191 APAC: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION) 186
TABLE 192 APAC: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION) 187
10.4 RESEARCH AND DEVELOPMENT 187
10.4.1 SUBS ARE INCREASINGLY ADOPTED FOR R&D APPLICATIONS AS IT IS AN ECONOMICAL AND FLEXIBLE OPTION 187
TABLE 193 SINGLE-USE BIOREACTORS MARKET FOR RESEARCH AND DEVELOPMENT,
BY REGION, 2017–2020 (USD MILLION) 187
TABLE 194 SINGLE-USE BIOREACTORS MARKET FOR RESEARCH AND DEVELOPMENT,
BY REGION, 2021–2026 (USD MILLION) 188
TABLE 195 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION) 188
TABLE 196 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION) 188
TABLE 197 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION) 189
TABLE 198 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION) 189
TABLE 199 APAC: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION) 189
TABLE 200 APAC: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION) 190
11 SINGLE-USE BIOREACTORS MARKET, BY END USER 191
11.1 INTRODUCTION 192
TABLE 201 SINGLE-USE BIOREACTORS MARKET, BY END USER,
2017–2020 (USD MILLION) 192
TABLE 202 SINGLE-USE BIOREACTORS MARKET, BY END USER,
2021–2026 (USD MILLION) 192
11.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 192
11.2.1 INCREASING PHARMACEUTICAL R&D SPENDING IS DRIVING THE DEMAND FOR SINGLE-USE BIOREACTORS 192
TABLE 203 SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2017–2020 (USD MILLION) 193
TABLE 204 SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021–2026 (USD MILLION) 193
TABLE 205 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION) 194
TABLE 206 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION) 194
TABLE 207 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION) 194
TABLE 208 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION) 195
TABLE 209 APAC: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION) 195
TABLE 210 APAC: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION) 195
11.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) AND CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) 196
11.3.1 INCREASING OUTSOURCING OF R&D SERVICES BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO SUPPORT THE MARKET GROWTH OF THIS END-USER SEGMENT 196
TABLE 211 SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY REGION,
2017–2020 (USD MILLION) 196
TABLE 212 SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY REGION,
2021–2026 (USD MILLION) 197
TABLE 213 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY COUNTRY, 2017–2020 (USD MILLION) 197
TABLE 214 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2026 (USD MILLION) 197
TABLE 215 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS,
BY COUNTRY, 2017–2020 (USD MILLION) 198
TABLE 216 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS,
BY COUNTRY, 2021–2026 (USD MILLION) 198
TABLE 217 APAC: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS,
BY COUNTRY, 2017–2020 (USD MILLION) 198
TABLE 218 APAC: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS,
BY COUNTRY/REGION, 2021–2026 (USD MILLION) 199
11.4 ACADEMIC & RESEARCH INSTITUTES 199
11.4.1 GROWING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO DRIVE THE MARKET GROWTH 199
TABLE 219 SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017–2020 (USD MILLION) 199
TABLE 220 SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2026 (USD MILLION) 200
TABLE 221 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION) 200
TABLE 222 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION) 200
TABLE 223 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION) 201
TABLE 224 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION) 201
TABLE 225 APAC: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION) 201
TABLE 226 APAC: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION) 202

12 SINGLE-USE BIOREACTORS MARKET, BY REGION 203

12.1 INTRODUCTION 204

FIGURE 31 SINGLE-USE BIOREACTORS MARKET, BY REGION,

2021 VS. 2026 (USD MILLION) 204

TABLE 227 SINGLE-USE BIOREACTORS MARKET, BY REGION,

2017–2020 (USD MILLION) 205

TABLE 228 SINGLE-USE BIOREACTORS MARKET, BY REGION,

2021–2026 (USD MILLION) 205

12.2 NORTH AMERICA 205

FIGURE 32 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SNAPSHOT 206

TABLE 229 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,

2017–2020 (USD MILLION) 207

TABLE 230 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,

2021–2026 (USD MILLION) 207

TABLE 231 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 207

TABLE 232 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 208

TABLE 233 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2017–2020 (USD MILLION) 208

TABLE 234 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2026 (USD MILLION) 208

TABLE 235 NORTH AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2017–2020 (USD MILLION) 209

TABLE 236 NORTH AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2026 (USD MILLION) 209

TABLE 237 NORTH AMERICA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION) 209

TABLE 238 NORTH AMERICA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION) 210

TABLE 239 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE

OF MOLECULE, 2017–2020 (USD MILLION) 210

TABLE 240 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE

OF MOLECULE, 2021–2026 (USD MILLION) 210

TABLE 241 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION) 211

TABLE 242 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION) 211

TABLE 243 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2017–2020 (USD MILLION) 211

TABLE 244 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2026 (USD MILLION) 212

TABLE 245 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2017–2020 (USD MILLION) 212

TABLE 246 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2026 (USD MILLION) 212

12.2.1 US 213

12.2.1.1 The US dominates the North American single-use bioreactors market during the forecast period 213

TABLE 247 US: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 213

TABLE 248 US: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 214

TABLE 249 US: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2017–2020 (USD MILLION) 214

TABLE 250 US: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2021–2026 (USD MILLION) 214

TABLE 251 US: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2017–2020 (USD MILLION) 215

TABLE 252 US: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2021–2026 (USD MILLION) 215

TABLE 253 US: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2017–2020 (USD MILLION) 215

TABLE 254 US: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2021–2026 (USD MILLION) 216

TABLE 255 US: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2017–2020 (USD MILLION) 216

TABLE 256 US: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2021–2026 (USD MILLION) 217

TABLE 257 US: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2017–2020 (USD MILLION) 217

TABLE 258 US: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2021–2026 (USD MILLION) 217

12.2.2 CANADA 218

12.2.2.1 A growing number of biopharmaceutical manufacturing facilities supports market growth in Canada 218

FIGURE 33 CANADA BIOLOGICS SALES (2009-2018) 218

TABLE 259 CANADA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 219

TABLE 260 CANADA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 219

TABLE 261 CANADA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2017–2020 (USD MILLION) 219

TABLE 262 CANADA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2021–2026 (USD MILLION) 220

TABLE 263 CANADA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION) 220

TABLE 264 CANADA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION) 220

TABLE 265 CANADA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2017–2020 (USD MILLION) 221

TABLE 266 CANADA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2021–2026 (USD MILLION) 221

TABLE 267 CANADA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2017–2020 (USD MILLION) 221

TABLE 268 CANADA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2021–2026 (USD MILLION) 222

TABLE 269 CANADA: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2017–2020 (USD MILLION) 222

TABLE 270 CANADA: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2021–2026 (USD MILLION) 222

12.3 EUROPE 223

TABLE 271 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,

2017–2020 (USD MILLION) 223

TABLE 272 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,

2021–2026 (USD MILLION) 223

TABLE 273 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 224

TABLE 274 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 224

TABLE 275 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2017–2020 (USD MILLION) 224

TABLE 276 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2026 (USD MILLION) 225

TABLE 277 EUROPE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,

2017–2020 (USD MILLION) 225

TABLE 278 EUROPE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,

2021–2026 (USD MILLION) 225

TABLE 279 EUROPE: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2017–2020 (USD MILLION) 226

TABLE 280 EUROPE: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2021–2026 (USD MILLION) 226

TABLE 281 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION) 226

TABLE 282 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION) 227

TABLE 283 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2017–2020 (USD MILLION) 227

TABLE 284 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2021–2026 (USD MILLION) 227

TABLE 285 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2017–2020 (USD MILLION) 228

TABLE 286 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2021–2026 (USD MILLION) 228

TABLE 287 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2017–2020 (USD MILLION) 228

TABLE 288 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2021–2026 (USD MILLION) 229

12.3.1 GERMANY 229

12.3.1.1 Increasing adoption of single-use bioreactors by biopharma companies and CDM0s to drive the market growth in Germany 229

TABLE 289 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 229

TABLE 290 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 230

TABLE 291 GERMANY: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2017–2020 (USD MILLION) 230

TABLE 292 GERMANY: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2021–2026 (USD MILLION) 230

TABLE 293 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION) 231

TABLE 294 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION) 231

TABLE 295 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2017–2020 (USD MILLION) 231

TABLE 296 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2021–2026 (USD MILLION) 232

TABLE 297 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2017–2020 (USD MILLION) 232

TABLE 298 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2021–2026 (USD MILLION) 232

TABLE 299 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2017–2020 (USD MILLION) 233

TABLE 300 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2021–2026 (USD MILLION) 233

12.3.2 UK 233

12.3.2.1 Rising government support for biotech companies to propel the demand for advanced technologies, including single-use bioreactors in the UK 233

TABLE 301 UK: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 234

TABLE 302 UK: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 234

TABLE 303 UK: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2017–2020 (USD MILLION) 234

TABLE 304 UK: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2021–2026 (USD MILLION) 235

TABLE 305 UK: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2017–2020 (USD MILLION) 235

TABLE 306 UK: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2021–2026 (USD MILLION) 235

TABLE 307 UK: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2017–2020 (USD MILLION) 236

TABLE 308 UK: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2021–2026 (USD MILLION) 236

TABLE 309 UK: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2017–2020 (USD MILLION) 236

TABLE 310 UK: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2021–2026 (USD MILLION) 237

TABLE 311 UK: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2017–2020 (USD MILLION) 237

TABLE 312 UK: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2021–2026 (USD MILLION) 237

12.3.3 FRANCE 238

12.3.3.1 Increasing investments in life sciences R&D infrastructure development to support the market growth in France 238

TABLE 313 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 238

TABLE 314 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 239

TABLE 315 FRANCE: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2017–2020 (USD MILLION) 239

TABLE 316 FRANCE: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2021–2026 (USD MILLION) 239

TABLE 317 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION) 240

TABLE 318 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION) 240

TABLE 319 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2017–2020 (USD MILLION) 240

TABLE 320 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2021–2026 (USD MILLION) 241

TABLE 321 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2017–2020 (USD MILLION) 241

TABLE 322 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2021–2026 (USD MILLION) 241

TABLE 323 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2017–2020 (USD MILLION) 242

TABLE 324 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2021–2026 (USD MILLION) 242

12.3.4 REST OF EUROPE (ROE) 242

TABLE 325 ROE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 243

TABLE 326 ROE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 243

TABLE 327 ROE: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2017–2020 (USD MILLION) 243

TABLE 328 ROE: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2021–2026 (USD MILLION) 244

TABLE 329 ROE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2017–2020 (USD MILLION) 244

TABLE 330 ROE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2021–2026 (USD MILLION) 244

TABLE 331 ROE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2017–2020 (USD MILLION) 245

TABLE 332 ROE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2021–2026 (USD MILLION) 245

TABLE 333 ROE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2017–2020 (USD MILLION) 245

TABLE 334 ROE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2021–2026 (USD MILLION) 246

TABLE 335 ROE: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2017–2020 (USD MILLION) 246

TABLE 336 ROE: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2021–2026 (USD MILLION) 246

12.4 ASIA PACIFIC 247

12.4.1 SIGNIFICANT INVESTMENTS BY BIOPHARMACEUTICAL COMPANIES & CMOS IN EMERGING APAC COUNTRIES TO DRIVE MARKET GROWTH 247

FIGURE 34 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET SNAPSHOT 248

TABLE 337 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,

2017–2020 (USD MILLION) 249

TABLE 338 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,

2021–2026 (USD MILLION) 249

TABLE 339 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 249

TABLE 340 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 250

TABLE 341 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2017–2020 (USD MILLION) 250

TABLE 342 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2026 (USD MILLION) 250

TABLE 343 ASIA PACIFIC: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2017–2020 (USD MILLION) 251

TABLE 344 ASIA PACIFIC: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2026 (USD MILLION) 251

TABLE 345 ASIA PACIFIC: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION) 251

TABLE 346 ASIA PACIFIC: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION) 252

TABLE 347 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION) 252

TABLE 348 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION) 252

TABLE 349 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2017–2020 (USD MILLION) 253

TABLE 350 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2021–2026 (USD MILLION) 253

TABLE 351 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2017–2020 (USD MILLION) 253

TABLE 352 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2021–2026 (USD MILLION) 254

TABLE 353 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2017–2020 (USD MILLION) 254

TABLE 354 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2021–2026 (USD MILLION) 254

12.4.2 CHINA 255

12.4.2.1 Government initiatives contribute to the growth of the biopharma industry, thus supporting market growth for SUBs 255

TABLE 355 CHINA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 256

TABLE 356 CHINA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 256

TABLE 357 CHINA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2017–2020 (USD MILLION) 256

TABLE 358 CHINA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2021–2026 (USD MILLION) 257

TABLE 359 CHINA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2017–2020 (USD MILLION) 257

TABLE 360 CHINA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2021–2026 (USD MILLION) 257

TABLE 361 CHINA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2017–2020 (USD MILLION) 258

TABLE 362 CHINA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2021–2026 (USD MILLION) 258

TABLE 363 CHINA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2017–2020 (USD MILLION) 258

TABLE 364 CHINA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2021–2026 (USD MILLION) 259

TABLE 365 CHINA: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2017–2020 (USD MILLION) 259

TABLE 366 CHINA: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2021–2026 (USD MILLION) 259

12.4.3 SOUTH KOREA 260

12.4.3.1 Increasing annual drug exports and quality manufacturing practices to drive the market growth in South Korea 260

TABLE 367 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 260

TABLE 368 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 261

TABLE 369 SOUTH KOREA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION) 261

TABLE 370 SOUTH KOREA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION) 261

TABLE 371 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION) 262

TABLE 372 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION) 262

TABLE 373 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION) 262

TABLE 374 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION) 263

TABLE 375 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2017–2020 (USD MILLION) 263

TABLE 376 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2026 (USD MILLION) 263

TABLE 377 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2017–2020 (USD MILLION) 264

TABLE 378 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2021–2026 (USD MILLION) 264

12.4.4 JAPAN 264

12.4.4.1 Expansion of pharmaceutical manufacturing plants in Japan has created growth opportunities for SUB companies 264

TABLE 379 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 265

TABLE 380 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 265

TABLE 381 JAPAN: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2017–2020 (USD MILLION) 266

TABLE 382 JAPAN: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2021–2026 (USD MILLION) 266

TABLE 383 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2017–2020 (USD MILLION) 266

TABLE 384 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2021–2026 (USD MILLION) 267

TABLE 385 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2017–2020 (USD MILLION) 267

TABLE 386 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2021–2026 (USD MILLION) 267

TABLE 387 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2017–2020 (USD MILLION) 268

TABLE 388 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2021–2026 (USD MILLION) 268

TABLE 389 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2017–2020 (USD MILLION) 268

TABLE 390 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2021–2026 (USD MILLION) 269

12.4.5 INDIA 269

12.4.5.1 The growth of the pharmaceutical industry creates significant demand for SUBs in India 269

TABLE 391 INDIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 269

TABLE 392 INDIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 270

TABLE 393 INDIA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2017–2020 (USD MILLION) 270

TABLE 394 INDIA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2021–2026 (USD MILLION) 270

TABLE 395 INDIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2017–2020 (USD MILLION) 271

TABLE 396 INDIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2021–2026 (USD MILLION) 271

TABLE 397 INDIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2017–2020 (USD MILLION) 271

TABLE 398 INDIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2021–2026 (USD MILLION) 272

TABLE 399 INDIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2017–2020 (USD MILLION) 272

TABLE 400 INDIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2021–2026 (USD MILLION) 272

TABLE 401 INDIA: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2017–2020 (USD MILLION) 273

TABLE 402 INDIA: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2021–2026 (USD MILLION) 273

12.4.6 ROAPAC 273

TABLE 403 ROAPAC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 274

TABLE 404 ROAPAC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 274

TABLE 405 ROAPAC: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2017–2020 (USD MILLION) 274

TABLE 406 ROAPAC: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2021–2026 (USD MILLION) 275

TABLE 407 ROAPAC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION) 275

TABLE 408 ROAPAC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION) 275

TABLE 409 ROAPAC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2017–2020 (USD MILLION) 276

TABLE 410 ROAPAC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2021–2026 (USD MILLION) 276

TABLE 411 ROAPAC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2017–2020 (USD MILLION) 276

TABLE 412 ROAPAC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2021–2026 (USD MILLION) 277

TABLE 413 ROAPAC: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2017–2020 (USD MILLION) 277

TABLE 414 ROAPAC: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2021–2026 (USD MILLION) 277

12.5 LATIN AMERICA (LATAM) 278

12.5.1 GROWTH IN THE GENERIC DRUG MARKET WILL INCREASE THE DEMAND FOR SINGLE-USE BIOREACTORS IN LATAM 278

TABLE 415 LATAM: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 278

TABLE 416 LATAM: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 278

TABLE 417 LATAM: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2017–2020 (USD MILLION) 279

TABLE 418 LATAM: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2026 (USD MILLION) 279

TABLE 419 LATAM: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,

2017–2020 (USD MILLION) 279

TABLE 420 LATAM: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,

2021–2026 (USD MILLION) 280

TABLE 421 LATAM: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2017–2020 (USD MILLION) 280

TABLE 422 LATAM: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2021–2026 (USD MILLION) 280

TABLE 423 LATAM: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2017–2020 (USD MILLION) 281

TABLE 424 LATAM: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2021–2026 (USD MILLION) 281

TABLE 425 LATAM: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2017–2020 (USD MILLION) 281

TABLE 426 LATAM: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2021–2026 (USD MILLION) 282

TABLE 427 LATAM: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2017–2020 (USD MILLION) 282

TABLE 428 LATAM: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2021–2026 (USD MILLION) 282

TABLE 429 LATAM: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2017–2020 (USD MILLION) 283

TABLE 430 LATAM: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2021–2026 (USD MILLION) 283

12.6 MIDDLE EAST AND AFRICA (MEA) 283

12.6.1 FUNDING INITIATIVES AND RESEARCH ACTIVITIES IN THIS REGION DRIVES THE MARKET GROWTH FOR SUBS 283

TABLE 431 MEA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2017–2020 (USD MILLION) 284

TABLE 432 MEA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 284

TABLE 433 MEA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2017–2020 (USD MILLION) 284

TABLE 434 MEA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2026 (USD MILLION) 285

TABLE 435 MEA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,

2017–2020 (USD MILLION) 285

TABLE 436 MEA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,

2021–2026 (USD MILLION) 285

TABLE 437 MEA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2017–2020 (USD MILLION) 286

TABLE 438 MEA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,

2021–2026 (USD MILLION) 286

TABLE 439 MEA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2017–2020 (USD MILLION) 286

TABLE 440 MEA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,

2021–2026 (USD MILLION) 287

TABLE 441 MEA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2017–2020 (USD MILLION) 287

TABLE 442 MEA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL,

2021–2026 (USD MILLION) 287

TABLE 443 MEA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2017–2020 (USD MILLION) 288

TABLE 444 MEA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,

2021–2026 (USD MILLION) 288

TABLE 445 MEA: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2017–2020 (USD MILLION) 288

TABLE 446 MEA: SINGLE-USE BIOREACTORS MARKET, BY END USER,

2021–2026 (USD MILLION) 289

13 COMPETITIVE LANDSCAPE 290

13.1 MARKET EVALUATION FRAMEWORK 290

13.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 290

FIGURE 35 SINGLE-USE BIOREACTOR MARKET: RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS 291

13.3 REVENUE ANALYSIS 292

FIGURE 36 REVENUE ANALYSIS FOR KEY COMPANIES FOR 2017-2020 292

13.4 MARKET SHARE ANALYSIS OF TOP MARKET PLAYERS 293

FIGURE 37 MARKET SHARE ANALYSIS: 2020 293

13.5 GLOBAL SINGLE-USE BIOREACTORS MARKET:

COMPANY EVALUATION QUADRANT, 2020 294

FIGURE 38 GLOBAL SINGLE-USE BIOREACTORS MARKET: COMPANY EVALUATION MATRIX, 2020 295

13.5.1 STARS 296

13.5.2 EMERGING LEADERS 296

13.5.3 PERVASIVE 296

13.5.4 EMERGING COMPANIES 296

13.6 GLOBAL SINGLE-USE BIOREACTORS MARKET: START-UPS/ SMES EVALUATION MATRIX, 2020 297

FIGURE 39 GLOBAL SINGLE-USE BIOREACTORS MARKET: STARTUP/SME EVALUATION MATRIX (2020) 297

13.6.1 PROGRESSIVE COMPANIES 298

13.6.2 STARTING BLOCKS 298

13.6.3 RESPONSIVE COMPANIES 298

13.6.4 DYNAMIC COMPANIES 298

13.7 COMPETITIVE BENCHMARKING 299

13.7.1 COMPANY PRODUCT FOOTPRINT (25 COMPANIES) 299

FIGURE 40 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE SINGLE-USE BIOREACTORS MARKET 299

13.8 KEY MARKET DEVELOPMENTS 300

13.8.1 KEY PRODUCT LAUNCHES 300

13.8.2 KEY ACQUISITIONS 300

13.8.3 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 301

13.8.4 KEY EXPANSIONS 302

14 COMPANY PROFILES 303

14.1 KEY PLAYERS 303

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win,

Strategic Choices Made, and Weaknesses and Competitive Threats))*

14.1.1 SARTORIUS STEDIM BIOTECH 303

TABLE 447 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 303

FIGURE 41 SARTORIUS STEDIM BIOTECH: COMPANY SNAPSHOT (2020) 304

TABLE 448 SARTORIUS STEDIM BIOTECH: PRODUCT OFFERINGS 304

14.1.2 DANAHER CORPORATION 309

TABLE 449 DANAHER: BUSINESS OVERVIEW 309

FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 310

14.1.3 THERMO FISHER SCIENTIFIC INC. 317

TABLE 450 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 317

FIGURE 43 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020) 318

TABLE 451 THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS 319

14.1.4 MERCK MILLIPORE 322

TABLE 452 MERCK MILLIPORE: BUSINESS OVERVIEW 322

FIGURE 44 MERCK MILLIPORE: COMPANY SNAPSHOT (2020) 323

TABLE 453 MERCK MILLIPORE: PRODUCT OFFERINGS 323

14.1.5 GETINGE AB 326

TABLE 454 GETINGE AB: BUSINESS OVERVIEW 326

FIGURE 45 GETINGE: COMPANY SNAPSHOT (2020) 327

TABLE 455 GETINGE AB: PRODUCT OFFERINGS 327

14.1.6 EPPENDORF AG 330

TABLE 456 EPPENDORF AG: BUSINESS OVERVIEW 330

FIGURE 46 EPPENDORF AG: COMPANY SNAPSHOT (2020) 331

TABLE 457 EPPENDORF AG: PRODUCT OFFERINGS 332

14.1.7 CESCO BIOENGINEERING CO., LTD. 335

TABLE 458 CESCO BIOENGINEERING CO., LTD.: BUSINESS OVERVIEW 335

TABLE 459 CESCO BIOENGINEERING CO., LTD.: PRODUCT OFFERINGS 335

14.1.8 CELLEXUS 337

TABLE 460 CELLEXUS: BUSINESS OVERVIEW 337

TABLE 461 CELLEXUS: PRODUCT OFFERINGS 337

14.1.9 PBS BIOTECH, INC. 339

TABLE 462 PBS BIOTECH: BUSINESS OVERVIEW 339

TABLE 463 PBS BIOTECH: PRODUCT OFFERINGS 339

14.1.10 DISTEK, INC. 340

TABLE 464 DISTEK INC.: BUSINESS OVERVIEW 340

TABLE 465 DISTEK, INC.: PRODUCT OFFERINGS 340

14.1.11 ABEC 342

TABLE 466 ABEC: BUSINESS OVERVIEW 342

TABLE 467 ABEC INC.: PRODUCT OFFERINGS 342

TABLE 468 PRODUCT LAUNCHES 343

14.1.12 ABLE CORPORATION & BIOTT CORPORATION 345

TABLE 469 ABLE CORPORATION & BIOTT CORPORATION: BUSINESS OVERVIEW 345

TABLE 470 ABLE CORPORATION & BIOTT CORPORATION: PRODUCT OFFERINGS 345

14.1.13 G&G TECHNOLOGIES, INC. 347

TABLE 471 G&G TECHNOLOGIES: BUSINESS OVERVIEW 347

TABLE 472 G&G TECHNOLOGIES: PRODUCT OFFERINGS 347

14.1.14 SOLIDA BIOTECH GMBH 348

TABLE 473 SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW 348

TABLE 474 SOLIDA BIOTECH GMBH: PRODUCT OFFERINGS 348

14.1.15 SATAKE CHEMICAL EQUIPMENT MFG., LTD. 350

TABLE 475 SATAKE CHEMICAL EQUIPMENT MFG., LTD.: BUSINESS OVERVIEW 350

TABLE 476 SATAKE CHEMICAL EQUIPMENTS MFG., LTD.: PRODUCT OFFERINGS 350

14.1.16 STOBBE PHARMA GMBH 351

TABLE 477 STOBBE PHARMA GMBH: BUSINESS OVERVIEW 351

TABLE 478 STOBBE PHARMA GMBH: PRODUCT OFFERINGS 351

14.1.17 CELLTAINER BIOTECH BV 352

TABLE 479 CELLTAINER BIOTECH: BUSINESS OVERVIEW 352

TABLE 480 CELLTAINER BIOTECH: PRODUCT OFFERINGS 352

14.1.18 MEISSNER FILTRATION PRODUCTS, INC. 353

TABLE 481 MEISSNER FILTRATION PRODUCTS INC.: BUSINESS OVERVIEW 353

TABLE 482 MEISSNER FILTRATION PRODUCTS INC.: PRODUCT OFFERINGS 353

14.1.19 BBI-BIOTECH GMBH 355

TABLE 483 BBI BIOTECH GMBH: BUSINESS OVERVIEW 355

14.1.20 PRODUCTS OFFERED 355

TABLE 484 BBI BIOTECH GMBH.: PRODUCT OFFERINGS 355

14.1.21 ENDEL ENGIE 356

TABLE 485 ENDEL ENGINE: BUSINESS OVERVIEW 356

TABLE 486 ENDEL ENGINE: PRODUCT OFFERINGS 356

14.2 START-UP PLAYERS 358

14.2.1 OMNIBRX BIOTECHNOLOGIES 358

14.2.2 NEW HORIZON BIOTECHNOLOGY INC. 359

14.2.3 GPC BIO 359

14.2.4 CELL CULTURE COMPANY 360

14.2.5 APTUS BIOREACTORS 361

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

15 APPENDIX 362

15.1 DISCUSSION GUIDE 362

15.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 366

15.3 AVAILABLE CUSTOMIZATIONS 368

15.4 RELATED REPORTS 368

15.5 AUTHOR DETAILS 369

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（耐久財）の最新刊レポート

MarketsandMarkets社の耐久財分野での最新刊レポート

本レポートと同じKEY WORD（media）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（耐久財）の最新刊レポート

MarketsandMarkets社の耐久財分野での最新刊レポート

本レポートと同じKEY WORD（media）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?